NEKTAR THERAPEUTICS AL, CORPORATION
Patent Owner
Stats
- 20 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jan 12, 2016 most recent publication
Details
- 20 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 604 Total Citation Count
- Apr 03, 1996 Earliest Filing
- 12 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2010/0303,753 Oligomer Conjugates of Lidocaine and Its DerivativesOct 17, 08Dec 02, 10[A61K, C08G, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0135,623 Conjugates of a Cholinesterase Moiety and a PolymerAbandonedMay 15, 09Jun 09, 11[A61K, C12N, A61P]
2011/0059,921 Oligomer-Nitrogenous Base ConjugatesAbandonedMar 27, 09Mar 10, 11[A61K, C07F, C07D, A61P]
2011/0009,589 DEGRADABLE HETEROBIFUNCTIONAL POLY(ETHYLENE GLYCOL) ACRYLATES AND GELS AND CONJUGATES DERIVED THEREFROMAbandonedAug 20, 10Jan 13, 11[C08F]
2010/0284,960 Dosage Forms and Co-Administration of Opioid Agonist and Opioid AntagonistAbandonedNov 07, 07Nov 11, 10[A61K, A61P]
2010/0152,201 Oligomer-Antihistamine ConjugatesAbandonedMar 12, 08Jun 17, 10[A61K, C07D, C07C, A61P]
2003/0161,791 Water-soluble polymer conjugates of retinoic acidAbandonedOct 30, 02Aug 28, 03[A61K, A61L]
2003/0143,185 Polymer conjugates of protein kinase C inhibitorsAbandonedOct 29, 02Jul 31, 03[A61K, C08G, C07K]
2003/0017,504 Antibodies specific for poly(ethylene glycol)AbandonedMay 21, 02Jan 23, 03[G01N, C07K]
2002/0182,172 Water-soluble polymer conjugates of triazine derivativesAbandonedNov 30, 01Dec 05, 02[A61K, C08F]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.